dc.description.abstract |
Hearing loss is a common neurosensory impairment, which has a significant genetic
etiology. A hearing loss affects 1 in 1000 newborns and 1 in 300 children by the age of
4 years (Chang 2015). It has been estimated that 1% of almost 30,000 protein coding
genes in human are associated with hearing phenotype (Friedman and Griffith 2003).
The mechanism of hearing is not fully understood because of the challenges associated
with studying inner ear architecture, but nonetheless some of the key genes encoding
distinct mechanisms of hearing have been explored by using genetic tools. Recent
studies in the field of human genetics have been influential in identifying some of the
proteins underlying mechanisms essential for sound transduction, as for example, hair
cells electromotility, mechanotransduction, development of inner and outer hair cells,
and the molecular composition of the ribbon synapse.
Using a genetic approach, this thesis research project explored novel genes involved in
non-syndromic and syndromic forms of hearing loss. Participants from 85 families that
are segregating moderate to severe degree of hearing loss are included in this study.
The affected individuals from 85 different families were initially screened for mutations
of GJB2 and HGF. Genetic variants of these two genes are common in the Pakistani
population and there is only one protein-coding exon of GJB2 and two common intronic
mutations of HGF which are easily sequenced for mutations. I have identified twenty
five novel mutations in genes that have been associated with hearing loss and all of the
identified novel mutations are predicted to be pathogenic according to multiple in silico
tools and have an allele frequency less than 0.005%. Mutations of MYO15A, GJB2 and
HGF are the three-major contributors to deafness in this cohort of eighty-five families.
In this thesis research project, I have successfully utilized some of the latest techniques in genetics that includes Whole Exome Sequencing (WES), genome wide SNP
genotyping, and Whole Genome Sequencing (WGS) and was able to identify novel
genes involved in syndromic and non-syndromic forms of deafness. In family
PKDF1400, I completed genome wide SNP genotyping of affected and unaffected
individuals. Genotyping data revealed a significant linkage score on chromosome
19p13.2 that encompasses DFNB68 locus. Individuals from PKDF1400 were then
subjected to WES and I identified a missense pathogenic variant of S1PR2
(p.Tyr140Cys). Sanger sequencing of the single nucleotide variant revealed co
segregation with the phenotype in PKDF1400. This thesis project has contributed data
in identifying a novel gene underlying DFNB68 form of deafness (Santos-Cortez et al.
2016).
I also identified a variant of SGO2 that is necessary for fertility in a Perrault syndrome
proband of family PKDF063, which was ascertained from Pakistan. Whole exome
sequencing of affected and unaffected members of PKDF063 revealed a truncating
mutation of SGO2 p.(Glu485Lysfs*5) associated with the proband’s infertility
phenotype. This is the first report of an association of SGO2 with human infertility
(Faridi et al. 2017).
I was successful in identifying a rare truncating mutation in family PKDF461 using
Whole genome sequencing. PKDF461 was ascertained as a family segregating non
syndromic hearing loss. The family has significant linkage of deafness to the DFNB8/10
interval which was further narrowed after analyzing WGS data that revealed a novel
nonsense mutation of KCNE1 (p.Tyr46*). Mutations of KCNE1 are associated with
Jervell and Lange Nielson syndrome (JLNS2) but this is the first truncating mutation
of this gene. Overall, this thesis research project has identified novel gene for human hearing and
fertility and has expanded the genotype-phenotype spectrum associated with Perrault
syndrome and Jervell and Lange Nielson syndrome. This study has contributed twenty
five novel genetic variants in several different genes that are critical for normal auditory
function. Overall, this research project utilized cutting-edge genomic technologies that
have revealed molecular genetic explanations for hereditary hearing loss in human
families and was successful in identifying novel genes for non-syndromic and
syndromic forms of hearing loss. |
en_US |